Elysium Therapeutics has raised $7.5M in a SAFE round to develop its SOOPR technology for reversing synthetic opioid overdoses. This funding will help accelerate the development of critical treatments for opioid overdose.
Amount Raised
$7.5 Million
Round Type
Convertible Note
AkronBiotechnologyHealthcareDescription
Elysium Therapeutics, a biopharmaceutical company based in Lyons, CO, has closed a $7.5M SAFE round. The funding will be used to accelerate the development of its SOOPR (Synthetic Opioid Overdose Protection and Reversal) technology. This technology aims to address overdoses caused by synthetic opioids, including fentanyl. Led by CEO Greg Sturmer, Elysium is dedicated to enhancing safety standards in the opioid industry.
Who else raised in Healthcare and Biotechnology around the same time
Companies in the same sectors as Elysium Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Artelo Biosciences raised $237K on March 12, 2026.
- Artelo Biosciences raised $113K on March 12, 2026.
- Monteris Medical raised $28M (Series E) on March 12, 2026.
- Tenon Medical raised $4.3M on March 11, 2026.
- Os Therapies raised $2M on March 4, 2026.
- Singletto raised $100K on March 2, 2026.
Who to call at Elysium Therapeutics, and when
A new round usually means Elysium Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Elysium Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Elysium Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Elysium Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Elysium Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Elysium Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.